GlassScriptPhysician profile
Nicolas Zingas
NPI 1568167385
$1,591.28
in general payments reported to CMS, 2019-2025
8 companies · $928 in 2025
The $928 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $663 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Travel and Lodging: $2.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.19 |
| Travel and Lodging | $2.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $789.77 | 2024-2025 | Persona, Juggerknotless Soft Anchor, Rosa |
| Stryker Corporation | $171.36 | 2025 | Aequalis Ascend Flex, Blueprint Patient Specific Instrumentation |
| Pinnacle, INC | $165.61 | 2024-2025 | |
| Avanos Medical | $143.87 | 2025 | On-Q Pump and Accessories |
| E.R. Squibb & Sons, L.L.C. | $121.35 | 2024 | Camzyos |
| Heron Therapeutics, INC. | $121.35 | 2024 | Zynrelef |
| Ethicon US, LLC | $58.03 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal, Stratafix |
| Depuy Synthes Sales INC. | $19.94 | 2025 | Healix Knotless Peek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Zingas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.